Market capitalization of Indian drug makers has taken a hit as the US FDA rains warnings against manufacturing practices, The Pharma letter’s Anjali Shukla trac 6 January 2016
The Pharma Letter’s Katie Osborne takes an in-depth look at the European Federation of Pharmaceutical Industries and Associations' (EFPIA) new disclosure code a 21 December 2015
If the current trend is any testimony.Indian pharma companies are gradually breaking into the field of research and development to create new molecules.switchin 14 December 2015
On 6 November the World Trade Organization (WTO) finally agreed.after two weeks of negotiations with the United States.to extend a waiver to allow the Least Dev 1 December 2015
Last week’s $160 billion megamerger between US pharma giant Pfizer (NYSE: PFE) and Irish-based Allergan provoked a huge reaction globally. The Pharma Letter's K 30 November 2015
With the US Senate launching an investigation into the steep drug price hikes, the ongoing debate on the pharmaceutical industry’s pricing mechanism is once aga 5 November 2015
Doctors without Borders / Médecins Sans Frontières (MSF) on Friday called for the removal of access to medicines provisions in the Trans-Pacific Partnership (TP 24 July 2015
Indian pharma companies may finally be looking at a better rate of clearances from the US Food and Drug Administration (FDA) as the third year of GDUFA (Generic 22 July 2015
The breakthrough achieved by Dutch bacterial specialist Micreos is the most promising development the sector has seen in decades, as the company has this week l 7 November 2014
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.